Usage Restrictions
In publishing, a citation of the following literature(s) designated by the DEPOSITOR is requested.
In publishing, an acknowledgment to the DEPOSITOR is requested.
The recipient of BIOLOGICAL RESOURCE shall obtain a prior written consent on use of it from the DEPOSITOR.
For a breeding use, a new contract must be concluded between the DEPOSITOR and the recipient.
After finishing the defined period in the contract, the recipient requires immediate stop of breeding.
References
Minami M et al. (1985) Stroke 16: 44-48.
Togashi H et al. (1996) Stroke 27: 520-526.
Togashi H et al. (1994) Neurosci Lett 166: 117-120.
Nakamura H et al. (1999) Eur J Pharmacol 380: 81-89.
Nakamura H et al. (2001) Brain Res 897: 82-92.
Ueno K-I et al. (2002) Behav Pharmacol 13: 1-13.
上野健一ら(2003) 日本神経精神薬理学雑誌 23: 47-55.
Ueno K-I et al. (2002) J Pharmacol Exp Ther 302: 95-100.
Togashi H et al. (2002) Neurosci Lett 320: 109-112.
Ueno K-I et al. (2003) Biogenic Amines 17: 293-312.
Togashi H et al. (2003) SHR News Letter 14
Hiraide S, Ueno K, Yamaguchi T, Matsumoto M, Yanagawa Y, Yoshioka M, Togashi H.
Behavioural effects of monoamine reuptake inhibitors on symptomatic domains in an animal model of attention-deficit/hyperactivity disorder.
Pharmacol Biochem Behav. 2013 Apr;105:89-97.